• Careers
  • Support

2019 Webinars

Outer layer of the Zika virus rendering showing gold rods embedded into blue beads. Webinar

Building a Zika virus vaccine: From global health to virus–like particle technology

Currently, there are no vaccines approved for use in the prevention of Zika. In this webinar, we discuss the development of several novel Zika virus-like particle (Zika-VLP)–based vaccine candidates and will provide data demonstrating their ability to induce a strong immune response and provide a high level of protection against Zika virus in murine animal models.

Connecting fluorescent red, yellow, green, and purple stands. Webinar

Cell Culture Fundamentals: Your Questions Answered

In this webinar an ATCC expert taps into ATCC’s vast experience and shares the best practices for culturing cells that ensure optimal results and performance. The information delivered covers all aspects of successful cell culture, including culture initiation, expansion, authentication, and cryopreservation.

Fluorescent blue, red, and green colon cells. Webinar

EMT and MET reporter cell lines: Elevating biological models of metastasis

Epithelial-to-mesenchymal transition (EMT) and its reverse (MET) are physiological mechanisms implicated in cancer metastasis. Watch this webinar to learn how CRISPR/Cas9 genome-editing technology was applied to develop a number of RFP- or GFP-tagged reporter cell lines to study EMT and MET phenomena.

Green fluorescent mitochondria in 895 Sk cells. Webinar

CRISPR/Cas9-engineered 3-D Tissue Culture Models of Drug-resistant Melanoma

Watch the presentation to learn how CRISPR/Cas9 genome-editing technology was used to introduce a specific point mutation that confers drug resistance into A375 melanoma line, and consider data indicating that this isogenic cell line is resistant to MEK and BRAF inhibitors and sensitive to therapies targeting upstream and downstream elements of the Ras/Raf-MAPK signaling pathway.

Kidney glomeruli rotate. Webinar

The Application of hTERT-immortalized Primary Cells in Toxicological Assays

Developing cell-based assays can be problematic; the cells must be physiologically relevant for the assay to be predictive, yet sufficiently abundant to be included in the assay without introducing interexperimental variability. Watch this webinar to learn how hTERT-immortalized primary cells exhibit the growth characteristics of cell lines while providing the physiological attributes of primary cells.

Fluorescent orange and lime green spheres of white blood cells. Webinar

iPSC-derived Primary Cells Expand Your Cell-based Assays With an Unlimited, Biologically Relevant Source

Differentiated induced pluripotent stem cell (iPSC)-derived cells fulfill the need for a consistent source of cells and physiological relevance. This webinar provides data demonstrating how differentiated iPSC-derived cells can be incorporated into immunoassays or further differentiated into cell types such as osteocytes, chondrocytes, and adipocytes.

White, dry, fuzzy, clusters of bacteria. Webinar

Making Sense Out of Microbiome Data – The Importance of Standards

With the undeniable variability in next-generation sequencing data, it is essential that standards are incorporated at each stage of the workflow. In this webinar, we provide an overview on the current challenges in microbiome research and demonstrate the application of mock microbial communities in assay development and standardization.

Clusters of blue and green exosomes. Webinar

On the Edge of the Bubble: Use of Exosomes as Reference Materials in Biomedical Research

Watch this webinar to hear an overview of exosomes from various well-characterized ATCC cell lines and data indicating that these extracellular vesicles can be used as reference materials in biological research and assay development.

Concentric circles with purple, orange and yellow markers for DNA sequencing. Webinar

Prevent Analysis Variability by Using NGS-authenticated Microbial Genomes

As part of our commitment to advancing authentication in life science research, ATCC has implemented a robust NGS and genome assembly workflow to enrich the characterization of biological materials in our collection. In this webinar, we detail the standardized process and quality control criteria that we use to produce reference-quality genomes.

Purple, fragmented DNA double helix strand on a black background. Webinar

Simplifying assay development with molecular standards

Reliable controls are a critical component in the development of molecular-based assays. In this webinar, we cover ATCC’s growing offering of quantitative genomic and synthetic molecular standards and we provide application data demonstrating the potential use of these products in diagnostic assay development.

Closeup of red and brown tick on a blade of grass. Webinar

Tick-borne Diseases: Developing Molecular Approaches to Detect Babesiosis

Tick-borne diseases (TBD) among humans are on the rise in the United States as urbanization along previously unpopulated areas continues. In this webinar, we will provide an overview of TBD epidemiology, the current status of diagnostic methods, and resources available from ATCC that advance TBD research priorities.

Blue and green 488 ck20 organoid cells. Webinar

Transforming In Vitro Cancer Research With Next-generation Biological Models from the Human Cancer Models Initiative

There is an unmet need for preclinical cancer models that better reflect the genotype and phenotype across the spectrum of cancer found in the patient population. Watch this webinar to hear about the wide variety of patient-derived in vitro cancer models ATCC offers in collaboration with HCMI, including organoids, neurospheres, and conditionally reprogrammed cells.